Agios (AGIO) accounting officer sells shares to cover RSU tax withholding
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
AGIOS PHARMACEUTICALS, INC. principal accounting officer Theodore James Washburn Jr. reported multiple equity transactions linked to restricted stock units. On March 1, 2026, he received a grant of 8,452 restricted stock units, each representing a contingent right to one share of common stock, vesting in three equal annual installments beginning March 1, 2027.
On March 2, 2026, restricted stock units granted in 2023, 2024 and 2025 vested, with 2,350, 2,450 and 2,695 units respectively converting into common stock at no cost. To cover tax withholding obligations from these vestings, he sold a total of 2,223 shares of common stock in open-market transactions at $28.96 per share pursuant to durable automatic sale instructions under Rule 10b5‑1. Following these transactions, he held 6,140 common shares directly, including 75 shares acquired through the company’s employee stock purchase plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 2,223 shares ($64,378)
Net Sell
10 txns
Insider
Washburn Theodore James Jr.
Role
Principal Accounting Officer
Sold
2,223 shs ($64K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted stock units | 2,350 | $0.00 | -- |
| Exercise | Restricted stock units | 2,450 | $0.00 | -- |
| Exercise | Restricted stock units | 2,695 | $0.00 | -- |
| Exercise | Common stock | 2,350 | $0.00 | -- |
| Sale | Common stock | 698 | $28.96 | $20K |
| Exercise | Common stock | 2,450 | $0.00 | -- |
| Sale | Common stock | 727 | $28.96 | $21K |
| Exercise | Common stock | 2,695 | $0.00 | -- |
| Sale | Common stock | 798 | $28.96 | $23K |
| Grant/Award | Restricted stock units | 8,452 | $0.00 | -- |
Holdings After Transaction:
Restricted stock units — 0 shares (Direct);
Common stock — 3,293 shares (Direct)
Footnotes (1)
- Includes 75 shares purchased through the Company's employee stock purchase plan. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2025. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units were granted on March 1, 2026. Beginning on March 1, 2027, the shares underlying the restricted stock units will vest in three equal annual installments. The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments. The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.
FAQ
What did AGIO officer Theodore Washburn report on this Form 4?
He reported vesting and conversion of several restricted stock unit awards into common stock and a new grant of 8,452 restricted stock units. He also disclosed related open-market sales of 2,223 shares to satisfy tax withholding obligations tied to those RSU vestings.
What new equity award did Theodore Washburn receive from AGIO?
He received a grant of 8,452 restricted stock units on March 1, 2026. Each restricted stock unit equals a contingent right to one share of Agios common stock, vesting in three equal annual installments beginning March 1, 2027, subject to the award terms.
Which AGIO restricted stock unit grants vested in these transactions?
Restricted stock units granted on March 1 of 2023, 2024, and 2025 vested in part. On March 2, 2026, 2,350, 2,450, and 2,695 units from those respective grants converted into common stock, consistent with three-year vesting schedules disclosed in the award footnotes.